Martin, Seth S.
for the AI-DPP Study Group
37 papers on CoChatORCID 0000-0002-7021-7622
Most cited papers
- Verified
Association of lowering low-density lipoprotein cholesterol with contemporary lipid-lowering therapies and risk of diabetes mellitus: a systematic review and meta-analysis
Khan, S. U., Rahman, H., Okunrintemi, V., Riaz, H., Khan, M. S., Sattur, S., Kaluski, E., Lincoff, A. M., Martin, S. S., & Blaha, M. J. (2019) · Journal of the American Heart Association
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 70
- Verified · note
Non–High-Density Lipoprotein Cholesterol, Guideline Targets, and Population Percentiles for Secondary Prevention in 1.3 Million Adults
Elshazly, M. B., Martin, S. S., Blaha, M. J., Joshi, P. H., Toth, P. P., McEvoy, J. W., Al-Hijji, M. A., Kulkarni, K. R., Kwiterovich, P. O., Blumenthal, R. S., et al. (2013) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 68
- Verified
Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites
Martin, S. S., Qasim, A. N., Mehta, N. N., Wolfe, M., Terembula, K., Schwartz, S., Iqbal, N., Schutta, M., Bagheri, R., & Reilly, M. P. (2009) · Diabetes
Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health
Cited by 60
- Verified
Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines
Sathiyakumar, V., Park, J., Quispe, R., Elshazly, M. B., Michos, E. D., Banach, M., Toth, P. P., Whelton, S. P., Blumenthal, R. S., Jones, S. R., et al. (2018) · Circulation
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 58
- Verified
Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
Albosta, M. S., Grant, J. K., Taub, P., Blumenthal, R. S., Martin, S. S., & Michos, E. D. (2023) · Vascular Health and Risk Management
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 51
- Verified
Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method
Whelton, S. P., Meeusen, J. W., Donato, L. J., Jaffe, A. S., Saenger, A., Sokoll, L. J., Blumenthal, R. S., Jones, S. R., & Martin, S. S. (2017) · Journal of Clinical Lipidology
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 48
- Verified
An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial
Mathioudakis, N., Lalani, B., Abusamaan, M. S., Alderfer, M., Alver, D., Dobs, A., Kane, B., McGready, J., Riekert, K., Ringham, B., et al. (2025) · JAMA
Mobile Health and mHealth ApplicationsArtificial Intelligence in Healthcare and Education
Cited by 41
- Verified
Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia)
Pallazola, V. A., Sathiyakumar, V., Park, J., Vakil, R. M., Toth, P., Lazo-Elizondo, M., Brown, E., Quispe, R., Guallar, E., Banach, M., et al. (2020) · Archives of Medical Science
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 38
- Verified
Trends in Glucagon-Like Peptide-1 Receptor Agonist Social Media Posts Using Artificial Intelligence
Javaid, A., Baviriseaty, S., Javaid, R., Zirikly, A., Kukreja, H., Kim, C. H., Blaha, M. J., Blumenthal, R. S., Martin, S. S., & Marvel, F. A. (2024) · JACC: Advances
Sentiment Analysis and Opinion MiningDiabetes Treatment and Management
Cited by 24
- Verified
Association Between Subclinical Thyroid Dysfunction and Fracture Risk
Daya, N. R., Fretz, A., Martin, S. S., Lutsey, P. L., Echouffo-Tcheugui, J. B., Selvin, E., & Juraschek, S. P. (2022) · JAMA Network Open
Thyroid Disorders and TreatmentsBone health and osteoporosis research
Cited by 18
- Verified
Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis
Quispe, R., Alfaddagh, A., Kazzi, B., Zghyer, F., Marvel, F. A., Blumenthal, R. S., Sharma, G., & Martin, S. S. (2022) · Current Atherosclerosis Reports
Fatty Acid Research and HealthLipoproteins and Cardiovascular Health
Cited by 17
- Verified
Importance of the triglyceride level in identifying patients with a Type III Hyperlipoproteinemia phenotype using the ApoB algorithm
Varghese, B., Park, J., Chew, E., Sajja, A., Brownstein, A., Pallazola, V. A., Sathiyakumar, V., Jones, S. R., Sniderman, A. D., & Martin, S. S. (2021) · Journal of Clinical Lipidology
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 12
- Verified
Abstract 26: The Corrie Myocardial infarction, COmbined-device, Recovery Enhancement (MiCORE) Study: 30-Day Readmission Rates and Cost-Effectiveness of a Novel Digital Health Intervention for Acute Myocardial Infarction Patients
Marvel, F. A., Spaulding, E. M., Lee, M., Yang, W., & Martin, S. S. (2019) · Circulation: Cardiovascular Quality and Outcomes
Mobile Health and mHealth ApplicationsCardiac Health and Mental Health
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free